Effectiveness, safety, and health-related quality of life outcomes in patients with hemophilia A receiving antihemophilic factor (recombinant) in a real-world setting: results of a 6-year interim analysis of the AHEAD International study

被引：0
|
作者：
Oldenburg, Johannes [1 ]
Ozelo, Margareth C. [2 ]
Klamroth, Robert [3 ]
Guillet, Benoit [4 ]
Khair, Kate [5 ]
Tsakiris, Dimitrios A. [6 ]
Botha, Jaco [7 ]
Fernandez, Alejandro [7 ]
Tang, Leilei [7 ]
Santagostino, Elena [8 ]
机构：
[1] Bonn Univ Clin, Inst Expt Hematol & Transfus Med, Bonn, Germany
[2] Univ Estadual Campinas, Hemoctr UNICAMP, Campinas, SP, Brazil
[3] Vivantes Klinikum Friedrichshain, Dept Internal Med Vasc Med & Haemostaseol, Berlin, Germany
[4] Univ Hosp Rennes, Hemophilia Treatment Ctr, Inserm U1085, IRSET, Rennes, France
[5] Great Ormond St Hosp Sick Children, Ctr Outcomes & Experience Res Childrens Hlth Illn, London, England
[6] Univ Basel Hosp, Basel, Switzerland
[7] Shire Int GmbH, Zug, Switzerland
[8] Maggiore Hosp Policlin, Fdn IRCCS Ca Granda, Angelo Bianchi Bonomi Hemophilia & Thrombosis Ctr, Milan, Italy
来源：
HAEMOPHILIA | 2020年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
MED-FP-005
引用
收藏
页码：95 / 96
页数：2
相关论文
共 50 条
  • [1] Joint Health Outcomes in Patients with Hemophilia A Receiving Antihemophilic Factor (Recombinant) in a Real-world Setting: Results of a 6-year Interim Analysis of the AHEAD International Study
    Khair, Kate
    Ozelo, Margareth
    Klamroth, Robert
    Guillet, Benoit
    Tsakiris, Dimitrios
    Botha, Jaco
    Fernandez, Alejandro
    Tang, Leilei
    Oldenburg, Johannes
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 : 74 - 74
  • [2] AHEAD INTERNATIONAL AND GERMAN STUDIES: 6-YEAR INTERIM EFFECTIVENESS AND SAFETY OUTCOMES IN PATIENTS WITH HEMOPHILIA A RECEIVING ANTIHEMOPHILIC FACTOR (RECOMBINANT) IN A REAL-WORLD SETTING
    Oldenburg, J.
    Ozelo, M. C.
    Klamroth, R.
    Guillet, B.
    Huth-Kuehne, A.
    Kurnik, K.
    Khair, K.
    Tsakiris, D. A.
    Botha, J.
    Fernandez, A.
    Regensburger, S.
    Tang, L.
    Santagostino, E.
    HAEMOPHILIA, 2020, 26 : 87 - 87
  • [3] Effectiveness and Safety Outcomes in Patients with Hemophilia a Receiving Antihemophilic Factor (Recombinant) for at Least 5 Years in a Real-World Setting: 6-Year Interim Analysis of the Ahead International and German Studies
    Tsakiris, Dimitrios A.
    Oldenburg, Johannes
    Klamroth, Robert
    Guillet, Benoit
    Khair, Kate
    Huth-Kuhne, Angela
    Kurnik, Karin
    Regensburger, Stephan
    Botha, Jaco
    Fernandez, Alejandro
    Tang, Leilei
    Ozelo, Margareth C.
    BLOOD, 2020, 136
  • [4] AHEAD international and German studies: Effectiveness, safety, and quality of life outcomes in hemophilia A patients treated with antihemophilic factor (recombinant) in a real world setting over 5 years
    Ozelo, M. C.
    Oldenburg, J.
    Huth-Kuhne, A.
    Klamroth, R.
    Parra, R.
    Kurnik, K.
    Santagostino, E.
    Tsakiris, D. A.
    Hermans, C.
    Jiang, H.
    Chiu, G. R.
    Renault, L.
    Fernandez, A.
    Khair, K.
    HAEMOPHILIA, 2019, 25 : 128 - 128
  • [5] 7TH INTERIM ANALYSIS OF ANTIHEMOPHILIC FACTOR (RECOMBINANT) AND JOINT HEALTH IN PATIENTS WITH HEMOPHILIA A: AHEAD INTERNATIONAL
    Khair, K.
    Oldenburg, J.
    Tsakiris, D. A.
    Klamroth, R.
    Guillet, B.
    Huth-Kuehne, A.
    Kurnik, K.
    Regensburger, S.
    Botha, J.
    Fernandez, A.
    Tang, L.
    Ozelo, M. C.
    HAEMOPHILIA, 2021, 27 : 36 - 36
  • [6] One-Year Interim Analysis of Health-Related Quality of Life in RRMS Patients Treated With Alemtuzumab in a Real-world Clinical Setting (LemQoL Study)
    Van Wijmeersch, B.
    Harrower, T.
    Hobart, J.
    Kizlaitiene, R.
    Marfia, G. A.
    Patti, F.
    Pearson, O. R.
    Van Pesch, V.
    Vanderdonckt, P.
    Vecsei, L.
    Shor, S.
    Achiron, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 1144 - 1144
  • [7] Real-World Effectiveness, Safety, and Health-Related Quality of Life in Patients Receiving Adjuvant Nivolumab for Melanoma in Belgium and Luxembourg: Results of PRESERV MEL
    Rogiers, Anne
    Willemot, Laurence
    McDonald, Laura
    Van Campenhout, Hilde
    Berchem, Guy
    Jacobs, Celine
    Blockx, Nathalie
    Rorive, Andree
    Neyns, Bart
    CANCERS, 2023, 15 (19)
  • [8] Health-Related Quality of Life and Survival in Prostate Cancer Patients in a Real-World Setting
    Bergius, Susanne
    Roine, Risto P.
    Taari, Kimmo
    Sintonen, Harri
    UROLOGIA INTERNATIONALIS, 2020, 104 (11-12) : 939 - 947
  • [9] Chronic Disease Outcomes As Predictors of Quality of Life in Patients with Hemophilia.: Data from the Real-World AHEAD International Study
    Ozelo, Margareth Castro
    Brighton, Sarah
    Grazzi, Enrico Ferri
    Hermans, Cedric
    Guerra, Randy
    Gu, Joan
    Oberai, Pooja
    BLOOD, 2023, 142
  • [10] Persistent effectiveness of prophylaxis with recombinant factor VIII concentrate in patients with hemophilia a in a real world setting over 4 years (international ahead study)
    Khair, K.
    Oldenburg, J.
    Baldacci, E.
    Parra, R.
    Steinitz-Trost, K. N.
    Gringeri, A.
    Pina, P.
    HAEMOPHILIA, 2018, 24 : 34 - 35
12345